Institute of Oncology Research (IOR)

#IORjobs We are looking for a motivated PostDoc to join our Functional Cancer Genomics Lab and contribute to innovative translational oncology projects in a dynamic and collaborative environment. Discover more about the position: ior.usi.ch/events-news/...

#IORnews On Thursday, April 30, 2026, we had the pleasure of hosting a distinguished delegation from the Department of Urology of West China Hospital of Sichuan University, Chengdu. Read more: ior.usi.ch/events-news/...

#IORnews Starting tomorrow, April 28–29, 2026, Lugano will host the International Prostate Cancer Symposium 2026, a key platform to explore the most promising emerging therapies and advance the future of precision medicine in prostate cancer care. 🔗 shorturl.at/lWOyn

#IORnews 👏 Arianna Baggiolini, Group Leader of the IOR Stem Cells and Cancer Laboratory, has been awarded the prestigious Young Investigator Grant from the Helmut Horten Foundation. Read the news: ior.usi.ch/events-news/...

#IORevents Join the 7th Castelgrande Lecture, promoted by Bios⁺, on May 12 at 17:00 at Castelgrande in Bellinzona. We are pleased to welcome Prof. Silvio Garattini, internationally renowned physician, pharmacologist, and founder of the Mario Negri Institute. Info & registration: shorturl.at/f8xQV

#IORnews New international collaborations with global partners extend IOR’s efforts to advance innovative therapies for blood cancers. Read more: ior.usi.ch/events-news/...

#IORnews In a recent interview, Prof. Cavalli and Prof. Alimonti — respectively President and Director of IOR, outlined the institute’s next steps, including new infrastructure, stronger collaboration, and a strategic focus on ageing research. Read more: shorturl.at/loNm0

#IORnews Tomorrow, the Annual Meeting of the International Extranodal Lymphoma Study Group (IELSG) begins in Bellinzona, bringing together global experts in the study and treatment of extranodal lymphomas. Read more: ior.usi.ch/events-news/...

#IORnews Major awards to IOR and IOSI at SOHC 2025 in Basel. Congratulations to Prof. Franco Cavalli, Prof. Davide Rossi, Prof. Anastasios Stathis, and Dr. Ghilardi for their well-deserved recognitions. Read more: ior.usi.ch/events-news/...

#IORnews 🎉 Congratulations to Dr. Lisa Pavinato, Postdoctoral Fellow in the Stem Cells and Cancer Lab led by Prof. Arianna Baggiolini on receiving the prestigious Brain & Behavior Research Foundation Young Investigator Grant! 🔗https://shorturl.at/BnMjx

#IORnews On the occasion of the 75th anniversary of Switzerland’s recognition of the People’s Republic of China, IOR and IOSI will represent Swiss scientific excellence at a high-level event in Beijing dedicated to oncology research collaboration. Read more: ior.usi.ch/events-news/...

#IORnews 🎉 Congratulations to Dr. Jonas Van Lent on receiving the prestigious AFM-Téléthon Trampoline Grant! This highly competitive grant supports promising early-career scientists developing bold and innovative projects in rare diseases. 🔗 shorturl.at/ghhNJ

#IORnews 🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer. Learn more: ior.usi.ch/events-news/...

#IORnews Congratulations to Prof. Davide Rossi, Group Leader at IOR and Deputy Head of Hematology at IOSI, on his appointment as Full Professor at USI within the Faculty of Biomedical Sciences. 🔗 ior.usi.ch/events-news/...

#IORnews IOR and IRB researchers (Theurillat & Cavalli labs) identify first-in-class inhibitors of FOXA1/FOXA2, long deemed “undruggable” drivers of prostate cancer. ➡️ Learn more: ior.usi.ch/events-news/...

#IORnews An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma. Learn more: ior.usi.ch/events-news/...

#IORjobs Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini: - PhD Student: ior.usi.ch/events-news/... - Lab Technician: ior.usi.ch/events-news/... Apply now and join Baggiolini’s international and inspiring team!

#IORnews IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies. 🔗Learn more: ior.usi.ch/events-news/...

#IORnews A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL. Learn more: tinyurl.com/ytybcbr8

#IORnews The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies. 🔗Read more: ior.usi.ch/events-news/... @calcinottolab.bsky.social

#IORnews Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement. Read more: shorturl.at/pLKnm

#IORnews Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer. Read more: shorturl.at/xqmAd

#IORjobs IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships. ⏳ IOR internal deadline: 3 August 2025 ➡️ Details & application procedure: shorturl.at/caVdu

#IORnews New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness. 🔗 Read the news: shorturl.at/wZWou

The Foundation for the IOR is deeply saddened by the sudden passing of Prof. Esteban Cvitkovic on June 20, 2025. A passionate supporter of our Institute and, until recently, a highly active member of our Scientific Advisory Board, he played a key role in shaping our research. 🔗 shorturl.at/QSUKp

#IORnews The 18th edition of the International Conference on Malignant Lymphoma (18-ICML), one of the most prestigious global events dedicated to lymphoid malignancies, concludes today after a week of intense scientific exchange and groundbreaking presentations. 🔗 ior.usi.ch/events-news/...

#IORnews 🏆 Prof. F. Cavalli, President of the IOR Foundation, has been selected as the 2025 inductee in the Lymphoma category by the Giants of Cancer Care program, a prestigious recognition that honors the world’s most distinguished cancer researchers and clinicians. ➡️ Read more: shorturl.at/j7dbB

#IORnews A Swiss study led by Prof. Davide Rossi opens the door to a new opportunity for patients with relapsed chronic lymphocytic leukemia. 📄 Read more: shorturl.at/bokQS

#IORjobs Open PhD Position! Join Arianna Baggiolini @ariannabaggiolini.bsky.social ’s Lab to work on human pluripotent stem cell (hPSC)-based models of the peripheral nervous system and disease. Info and application: ior.usi.ch/events-news/...

#IORnews 🎉 Congratulations to Dr. Bianca Calì, research associate in our Molecular Oncology Lab, for receiving the prestigious SAKK/Astellas GU-Oncology Award 2025! ➡️ Discover more about her winning study: shorturl.at/N2UaB

#IORnews Jonas Van Lent receives the Children's Tumor Foundation's Young Investigator Award. Congrats @jonasvanlent.bsky.social ! Read more: shorturl.at/ObLS5

#IORnews IOR researchers uncover a new mechanism linking senescent cells and immune suppression in prostate cancer, paving the way for improved therapies. ➡️ Discover more: shorturl.at/7PBJ0

#IORnews 🧬 New bioinformatic tool developed at IOR: EasyCircR. This open-source R package maps circRNA-miRNA-mRNA interactions, unlocking insights into gene regulation & cancer research. Discover more: shorturl.at/xjizN